
Giuliano Costa
@costagiuliano90
MD | Interventional cardiologist and researcher | AOU “Policlinico G. Rodolico-San Marco”, Catania, Italy
ID: 1190954041100185600
03-11-2019 11:29:16
137 Tweet
65 Followers
58 Following

1-year outcomes OPERA-TAVI registry finally out! 👉 No differences in mortality and re-hosp 👉Higher disabling stroke in Evolut PRO/PRO+ (2.6% vs. 0.4%). Selection bias? Real THV effect? It is time for more RCTs! #TAVI EuroIntervention Giuliano Costa eurointervention.pcronline.com/article/one-ye…

What you should know about the OPERA-#TAVI registry just published in EuroIntervention and presented at #PCRLV 2023! 🎥 Chiara De Biase interviewed first author Giuliano Costa

#PCRLV 2023 may be over, but the #science is here to stay⭐️ If busy again back home, here a handy overview of the results of the presented #TopLateBreakers ⤵️ Presented by: Philipp Lurz G.Nickenig, P.Nicz, @stolz_l G.Costa


Our recent study on PCI timing strategies in patients undergoing TAVI was among the most impactful articles in EuroIntervention 2023! Great collaborative work! This is a tribute to all co-workers involved in this project ! Marco Barbanti Giuliano Costa Michael Joner


x.com/JEscaned/statu… Davide Capodanno PCRonline 🫀

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters JACC Journals


💥TAVR in Small Annuli: SAPIEN ULTRA vs. Evolut PRO JACC Journals 🌐A SMART Trial-like design in a Real-World TAVR Registry 🔗 doi.org/10.1016/j.jcin… Azeem Latib @MatteoMSturla GCosta Marco Barbanti Montefiore Health System Albert Einstein College of Medicine - Official ⏳ What will the SMART RCT show American College of Cardiology?






Is there a simplified left atrial appendage closure pathway? Safety and efficacy of percutaneous closure without preprocedural imaging. A Research Letter Giuliano Costa george ramsay Claudio Sanfilippo Marco Barbanti #cardiotwitter #AHAJournals ahajrnls.org/3XDBKZb

Severe aortic wall thrombus is a strong predictor of embolic event and #stroke in transfemoral #TAVR #JACCINT Marc Bonnet @BrahimHarbaoui


Early discharge after uncomplicated TAVI could be the future standard, as Bagur et al. confirm its safety and feasibility. Tailored protocols and monitoring are key. Editorial perspective by Giuliano Costa Sofia Sammartino 👉👉 shorturl.at/f3gMA #TAVR #CardiologyInnovation


Mitral ViV replacement with S3U under local anaesthesia and no pacing. Immediate recovery and NDD! CTA planned and #Acunav ICE-guided trans-septal puncture #CVT #CataniaValveTheraphies Edwards TAVR Edwards Lifesciences Marco Barbanti


Do you need more BE THV sizes?This analysis from the OPERA-TAVI registry showed that the BE Sapien 3 ULTRA Edwards Lifesciences had similar VARC-3 early safety and device success in optimal or intermediate sizing zones 👉 eurointervention.pcronline.com/article/balloo…


This analysis of the OPERA-TAVI registry found SAPIEN 3 Ultra implantation in intermediate sizing zones achieves comparable device success and safety to optimal sizing, with similar annular rupture rates. Giuliano Costa Marco Barbanti ow.ly/sXeU50Vb4RS #EAPCI #TAVI



Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/Tenm50VSnw7 Rocco Montone EHJ Editor-in-Chief
